Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-10-18

Clinical Trial Update: Primary Care Amoxicillin Challenge [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating an amoxicillin challenge in primary care has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Amoxicillin Allergy | Phase 4 | Status: WITHDRAWN